Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
J-Kore Biopharmaceutical Research is a Shanghai-based biotechnology company specializing in the discovery and optimization of small molecule therapeutics. Founded in 2015 and located in the Zhangjiang Hi-Tech Park, the company operates as both a contract research organization (CRO) and an internal drug developer. Its core expertise encompasses medicinal chemistry, computer-aided drug design (CADD), and lead optimization for complex chemical entities. J-Kore primarily focuses on therapeutic areas such as oncology and metabolic disorders, aiming to deliver high-quality preclinical candidates. The company leverages an experienced scientific team to bridge the gap between early-stage hit identification and clinical development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 杰库生物医药研究.